Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merck & Co Inc (NYSE:MRK)

60.33
Delayed Data
As of Jan 19
 -0.84 / -1.37%
Today’s Change
47.97
Today|||52-Week Range
65.46
+2.48%
Year-to-Date

Today’s Trading

Previous close61.17
Today’s open61.05
Day’s range60.07 - 61.08
Volume11,397,928
Average volume (3 months)11,005,256
Market cap$166.3B
Dividend yield3.12%
Data as of 01/19/2017

Growth & Valuation

Earnings growth (last year)-61.67%
Earnings growth (this year)+5.20%
Earnings growth (next 5 years)+6.50%
Revenue growth (last year)-7.92%
P/E ratio30.8
Price/Sales3.87
Price/Book3.76

Competitors

 Today’s
change
Today’s
% change
NVSNovartis-1.46-2.03%
PFEPfizer-0.33-1.03%
SNYSanofi-0.59-1.45%
ABBVAbbVie-0.28-0.45%
Data as of 01/19/2017

Financials

Next reporting dateFebruary 2, 2017
EPS forecast (this quarter)$0.88
Annual revenue (last year)$38.8B
Annual profit (last year)$4.4B
Net profit margin11.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Kenneth C. Frazier
Chief Financial Officer &
Executive Vice President
Robert M. Davis
Corporate headquarters
Kenilworth, New Jersey

Forecasts


Search for Jobs